1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Serodus ASA - Product Pipeline Review - 2015

Serodus ASA - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 30 pages

Serodus ASA - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Serodus ASA - Product Pipeline Review - 2015’, provides an overview of the Serodus ASA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Serodus ASA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Serodus ASA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Serodus ASA’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Serodus ASA’s pipeline products

Reasons to buy

- Evaluate Serodus ASA’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Serodus ASA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Serodus ASA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Serodus ASA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Serodus ASA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Serodus ASA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Serodus ASA - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Serodus ASA Snapshot 5
Serodus ASA Overview 5
Key Information 5
Key Facts 5
Serodus ASA - Research and Development Overview 6
Key Therapeutic Areas 6
Serodus ASA - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Serodus ASA - Pipeline Products Glance 10
Serodus ASA - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Serodus ASA - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Serodus ASA - Drug Profiles 13
SER-100 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
SER-150 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
SER-130 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
SER-140 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Serodus ASA - Pipeline Analysis 19
Serodus ASA - Pipeline Products by Target 19
Serodus ASA - Pipeline Products by Route of Administration 20
Serodus ASA - Pipeline Products by Molecule Type 21
Serodus ASA - Pipeline Products by Mechanism of Action 22
Serodus ASA - Recent Pipeline Updates 23
Serodus ASA - Dormant Projects 26
Serodus ASA - Discontinued Pipeline Products 27
Discontinued Pipeline Product Profiles 27
piboserod hydrochloride 27
SER-101 27
Serodus ASA - Locations And Subsidiaries 28
Head Office 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 29
Disclaimer 30

List of Tables
Serodus ASA, Key Information 5
Serodus ASA, Key Facts 5
Serodus ASA - Pipeline by Indication, 2015 7
Serodus ASA - Pipeline by Stage of Development, 2015 8
Serodus ASA - Monotherapy Products in Pipeline, 2015 9
Serodus ASA - Phase II, 2015 10
Serodus ASA - Phase I, 2015 11
Serodus ASA - Preclinical, 2015 12
Serodus ASA - Pipeline by Target, 2015 19
Serodus ASA - Pipeline by Route of Administration, 2015 20
Serodus ASA - Pipeline by Molecule Type, 2015 21
Serodus ASA - Pipeline Products by Mechanism of Action, 2015 22
Serodus ASA - Recent Pipeline Updates, 2015 23
Serodus ASA - Dormant Developmental Projects,2015 26
Serodus ASA - Discontinued Pipeline Products, 2015 27

List of Figures
Serodus ASA - Pipeline by Top 10 Indication, 2015 7
Serodus ASA - Pipeline by Stage of Development, 2015 8
Serodus ASA - Monotherapy Products in Pipeline, 2015 9
Serodus ASA - Pipeline by Top 10 Target, 2015 19
Serodus ASA - Pipeline by Top 10 Route of Administration, 2015 20
Serodus ASA - Pipeline by Top 10 Molecule Type, 2015 21
Serodus ASA - Pipeline Products by Top 10 Mechanism of Action, 2015 22

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nordic Nanovector ASA (NANO) - Financial and Strategic SWOT Analysis Review

Nordic Nanovector ASA (NANO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Nordic Nanovector ASA (Nordic Nanovector) formerly Nordic Nanovector AS, is a biotechnology company which develops and commercializes antibody radionuclide conjugates (ARC) for the treatment of ...

PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review

PCI Biotech Holding ASA (PCIB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary PCI Biotech Holding ASA (PCI Biotech) a subsidiary of Photocure ASA is a biopharmaceutical company that offers cancer care solutions. The company offers development of therapeutic products based ...

Photocure ASA (PHO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Photocure ASA (PHO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Photocure ASA (Photocure) is a specialty pharmaceutical company with focus on dermatology and oncology. It develops and markets pharmaceuticals and medical devices for the diagnosis and treatment ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.